ALBANY, N.Y. (Oct. 3, 2023) — The 2023 Nobel Prize in Medicine has been awarded to scientists Katalin Karikó and Drew Weissman for laying the scientific foundation that enabled the development of the mRNA vaccine for COVID-19. The vaccine has…
Tag: Vaccine Research
LJI scientists harness ‘helper’ T cells to treat tumors
La Jolla Institute for Immunology (LJI) scientists have published a pair of studies that show how we might harness CD4+ T cells while boosting the cancer-fighting power of CD8+ “killer” T cells.
New algorithm may fuel vaccine development
Immune system researchers have designed a computational tool to boost pandemic preparedness. Scientists can use this new algorithm to compare data from vastly different experiments and better predict how individuals may respond to disease.
Finnish population-based study: Vulnerable groups were the least likely to uptake COVID-19 vaccination
A large-scale registry study in Finland has identified several factors associated with uptake of the first dose of COVID-19 vaccination. In particular, persons with low or no labor income and persons with mental health or substance abuse issues were less likely to vaccinate.
Vaccine hesitancy has become a nationwide issue: What can science do about it?
South Carolina residents were more hesitant than Americans as a whole to receive the COVID-19 vaccine during the fall of 2020, report researchers in the Department of Psychiatry and Behavioral Sciences at the Medical University of South Carolina (MUSC) in the Journal of Psychiatry Research.
First-line immune defences against COVID-19 are short-lived and may explain reinfection
A new study finds that antibodies produced in the nose decline nine months after COVID-19 infection, while antibodies found in the blood last at least a year.
Polarization after COVID-19: Global study published in Nature reveals that the unvaccinated face prejudice in most countries
Across all inhabited continents of the world, people show prejudice and discriminatory attitudes towards individuals not vaccinated against COVID-19.
LJI scientists confirm smallpox vaccine also teaches T cells to fight mpox
“Vaccines such as JYNNEOS should be able to induce T cells that also recognize mpox and can provide protection from severe disease.”
‘Prime and Spike’ nasal vaccine strategy helps combat COVID
A Yale-designed nasal vaccine can help bolster immune responses to COVID-19 in previously vaccinated animals and reduce viral transmission, Yale researchers report Oct. 27 in the journal Science.
The longer the bootcamp, the better the antibodies
LJI research shows that a “slow delivery, escalating dose” vaccination strategy can prompt B cells to spend months mutating and evolving their pathogen-fighting antibodies.
Rethinking the rabies vaccine
Rabies virus kills a shocking 59,000 people each year, many of them children. In a new study, researchers from La Jolla Institute for Immunology and Institut Pasteur share a promising path to better vaccine design.
LJI scientists publish first head-to-head comparison of four COVID-19 vaccines
“Just understanding the immune responses to these vaccines will help us integrate what is successful into vaccine designs going forward.”
LLNL joins Human Vaccines Project to accelerate vaccine development and understanding of immune response
Lawrence Livermore National Laboratory has joined the international Human Vaccines Project, bringing Lab expertise and computing resources to the consortium to aid development of a universal coronavirus vaccine and improve understanding of immune response.
Tip Sheet: Making clinical trials more inclusive, measuring COVID vaccine protection and new HIV vaccine results
SEATTLE — September 1, 2021 — Below are summaries of recent Fred Hutch research findings and other news.
Chula to Accelerate Research on “Rutin” — An Herbal Extract Against COVID-19
Chula researchers have found that “rutin” extract from orange peel can kill the COVID-19 virus. They are developing it into drugs while pointing out that drug research is still necessary along with vaccine research and suggesting that Thai people should adjust their views on herbs to create added value.
COVID-19 Vaccine Expert Available: Why You Should Sign up for Your Shot
The images are popping up on our social media feeds: pictures of friends, coworkers, and family members proudly displaying their COVID-19 vaccine card. One might have received Pfizer’s version. Another might have posted a celebratory confirmation of Moderna’s vaccine. It’s…
Rutgers Black Physician Shares Why She Joined Coronavirus Vaccine Clinical Trial
As the United States begins rolling out coronavirus vaccines, many people, especially those in the Black community, are still hesitant to participate when it becomes widely available. Valerie Fitzhugh, a Rutgers doctor discusses why she chose to participate in a coronavirus vaccine trial as a Black woman, wife, and mother of two children and encourages more people, particularly minorities, to be vaccinated.
George Washington University Public Health/Medical Experts Available for Media Interviews on COVID-19 Vaccine
On Dec. 17, a U.S. Food and Drug Administration panel is expected to review the data on the Moderna COVID-19 vaccine, paving the way for approval. Researchers at the George Washington University led one of the 100 clinical sites testing…
Rutgers Medical Schools’ Dean Explores the Importance of Medical Research Participation in Minority Communities
Rutgers medical schools’ Dean discusses the importance of Black and Latinx representation in clinical trial studies and the critical steps the medical community can take in rebuilding the trust in minority communities by more transparency and continuous education
Vaccine Opposition Online Uniting Around ‘Civil Liberties’ Argument
Anti-vaccination discourse on Facebook increased in volume over the last decade, coalescing around the argument that refusing to vaccinate is a civil right, according to a study published today in the American Journal of Public Health.
Rutgers Experts Explore Questions, Concerns Over COVID-19 Vaccine Trials
As researchers race to develop a COVID-19 vaccine, a Rutgers infectious disease expert and a Rutgers bioethicist discuss how clinical trials work, the ethics of developing and distributing a vaccine, safety and efficacy in clinical trials and what a successful vaccine may mean.
In victory over polio, hope for the battle against COVID-19
Medicine’s great triumph over polio holds out hope we can do the same for COVID-19, two researchers say.
Understanding How COVID-19 Affects Children Vital to Slowing Pandemic, Doctors Say
Though COVID-19 so far appears to be largely sparing children, researchers are cautioning that it is critical to understand how the virus affects kids to model the pandemic accurately, limit the disease’s spread and ensure the youngest patients get the care they need.